Hepatitis C virus (HCV) is a major cause of morbidity and mortality worldwide. The infection
becomes chronic in about 85% of infected individuals, in the face of a strong humoral and …

Hepatitis C virus (HCV) infection is a prevalent infection in most developed countries
affecting 1.5–2% of the general population [1]. The natural history of this infection has been …

The natural history of hepatitis C virus (HCV) infection following liver transplantation and
predictors of disease severity remain controversial. The aims of the study were to assess in a …

Decompensated liver disease associated with chronic hepatitis C virus (HCV) infection is the
most common indication for liver transplantation. It was shown previously that greater …

Hepatitis C virus (HCV) infection represents an important public health problem worldwide.
Reduction of HCV morbidity and mortality is a current challenge owned to several viral and …

Background & Aims: The present organ shortage has brought into question the suitability of
hepatitis C virus (HCV)-positive grafts. This study reviewed the outcome of such …

Hepatitis C virus (HCV) cirrhosis is the most common indication for liver transplantation in
developed countries. Re-infection of liver allografts is virtually universal and occurs at …

The advent of genotyping assays has stimulated investigators around the world to study the
molecular epidemiology of hepatitis C virus (HCV) infection in specific patient categories, as …

A perfect or nearly perfect human leukocyte antigen (HLA) match has been associated with
better immediate and long‐term survival of diseased donor kidney transplants. However, the …

Recurrence of hepatitis C (HCV) following liver transplantation is common. Herpesvirus
reactivation following transplant may have an immunomodulatory effect resulting in …